Paradoxical lucidity in severe end stage dementia: a mixed methods prospective study
严重末期痴呆的矛盾清醒:一项混合方法前瞻性研究
基本信息
- 批准号:10095286
- 负责人:
- 金额:$ 42.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdverse eventBiologicalBiological MarkersBrainCaregiversCerebral IschemiaCerebrumCessation of lifeCharacteristicsCognitiveConsciousConsentDataDementiaElderlyElectroencephalographyEpidemiologyEventFactor AnalysisFamilyFamily CaregiverFocus GroupsFrequenciesFutureHeart ArrestImpaired cognitionIncidenceLife ExpectancyLocationMeasurementMethodsMonitorNatureNear-Death ExperienceNeurobiologyNeurologicNew YorkNursing HomesNursing ServicesPalliative CarePatientsPhasePreparationProspective StudiesProspective cohort studyQuestionnairesRecordsReportingResearchResourcesServicesSiteStudy SubjectSurveysSymptomsTestingTherapeuticTherapeutic InterventionTimeVisiting Nurseadvanced dementiabasecognitive functioncostdesigndiariesend of lifehospice environmentinsightmultidisciplinarynovelphenomenological modelspreventprimary outcomerecruitsafety and feasibilitysafety outcomessecondary outcometheoriestool
项目摘要
Project Summary/Abstract
Dementia is expected to impact 75 million people by 2030. It is inevitably considered progressive and irreversible
in nature and culminates into an advanced stage. However, paradoxical episodes of unexpected cognitive
lucidity (paradoxical lucidity [PL]) especially near the end of life have been reported anecdotally for years in
patients with advanced dementia. Although, little is known about PL, yet if confirmed systematically, its
occurrence may challenge current assumptions and highlight the possibility of a network-level return of cognitive
function. This may provide novel insights into the underlying neurobiology and delineate future therapeutic
possibilities. While, there is no definition of PL, and no systematic studies have assessed the epidemiology,
neurologic underpinnings, and phenomenology of PL in dementia, however, lucidity and/or consciousness with
phenomenological similarities to PL have been described during other brain states which are also not expected
to support lucidity. This includes severe cerebral ischemia in cardiac arrest (CA) (at times referred to as near-
death experiences [NDE]). Some data suggests these lucid death related episodes may correlate with surges in
electrocortical activity, which may in turn provide mechanistic insights and biological plausibility for PL in severe
dementia. We have pioneered research into NDE’s and found a similar phenomenology to PL in severe
dementia. Our team has conducted largescale multisite studies, including a current 20-site study of NDE’s in
1500 CA subjects with real-time biomarkers of electrocortical activity using electroencephalography (EEG). We
are proposing to test the hypothesis that patients with advanced end stage dementia with an estimated life
expectancy 7 days can be successfully identified and recruited into a study exploring episodes of PL at the end
of life. Furthermore, we hypothesize that the use of symptom diaries and video, audio and EEG monitoring will
be feasible and deemed not sufficiently intrusive to prevent its use for patients or their families at the end of life
in a larger prospective study.Through a multidisciplinary team, including the Visiting Nurse Service of New York’s
(VNSNY) hospice services we aim to systematically study the phenomenology, characteristics, and
electrocortical biomarkers of PL in dementia and create a measurement scale.The R21 phase aims are 1) To
obtain necessary and sufficient data to determine the safety and feasibility of using symptom diaries and real-
time video EEG monitoring for a future study of PL in advanced dementia 2) To obtain necessary and sufficient
data to design a prospective cohort study of PL in advanced dementia and its underlying cerebral electrocortical
biomarkers The R33 phase aims are to 3) Conduct a mixed methods prospective study of PL during end stage
advanced dementia 4) Create a definition and measurement scale for PL in advanced dementia and to 5) Explore
the potential electrocortical biomarkers of PL in advanced dementia.
项目总结/摘要
预计到2030年,痴呆症将影响7500万人。它不可避免地被认为是渐进的和不可逆转的
并最终进入高级阶段。然而,意外认知的矛盾事件
清醒(矛盾的清醒[PL]),特别是在生命的尽头,多年来一直有轶事报道,
晚期痴呆患者。虽然对PL知之甚少,但如果系统地证实,
发生可能会挑战目前的假设,并强调网络层面的认知回归的可能性。
功能这可能为潜在的神经生物学提供新的见解,并描绘未来的治疗方法。
可能性然而,PL没有定义,也没有系统的研究评估流行病学,
神经学基础和痴呆PL的现象学,然而,清醒和/或意识,
在其他大脑状态下,也描述了与PL的现象学相似性,这也是意料之外的
来支持清醒。这包括心脏骤停(CA)中的严重脑缺血(有时称为近-
死亡经历(NDE)。一些数据表明,这些与清醒死亡有关的事件可能与脑死亡的激增有关。
皮层电活动,这反过来可能提供机制的见解和生物学可解释性PL在严重
痴呆我们已经率先研究了NDE的,并发现了一个类似的现象,PL在严重
痴呆我们的团队已经进行了大规模的多地点研究,包括目前的20个地点的NDE的研究,
1500名CA受试者使用脑电图(EEG)进行皮层电活动的实时生物标志物。我们
正在提议测试一个假设,即晚期痴呆患者的估计寿命
可以成功地确定预期时间> 7天,并将其招募到研究结束时PL发作的研究中
生命此外,我们假设,使用症状日记和视频,音频和脑电图监测将
可行,并且被认为不足以阻止患者或其家属在生命结束时使用
在一项更大的前瞻性研究中,通过一个多学科小组,包括纽约的探访护士服务,
(VNSNY)安宁疗护服务,我们的目标是系统地研究安宁疗护服务的现象、特征,
R21阶段的目标是:1)
获得必要和充分的数据,以确定使用症状日记和真实的-
时间视频脑电图监测为未来的研究PL在先进的痴呆2)为了获得必要的和充分的
设计一项关于晚期痴呆患者PL及其潜在大脑皮层电活动的前瞻性队列研究
生物标志物R33阶段的目标是3)在终末期期间进行PL的混合方法前瞻性研究
晚期痴呆4)创建晚期痴呆PL的定义和测量量表,并5)探索
晚期痴呆患者PL的潜在皮层电生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sam Parnia其他文献
Sam Parnia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sam Parnia', 18)}}的其他基金
Neuroprotection following cardiac arrest: A Randomized Control Trial of Magnesium
心脏骤停后的神经保护:镁的随机对照试验
- 批准号:
10742460 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Goal directed cardiopulmonary resuscitation in cardiac arrest using a novel physiological target: A pilot mechanistic randomized control trial
使用新型生理目标进行心脏骤停的目标导向心肺复苏:一项试点机械随机对照试验
- 批准号:
10698018 - 财政年份:2020
- 资助金额:
$ 42.82万 - 项目类别:
Paradoxical lucidity in severe end stage dementia: a mixed methods prospective study
严重末期痴呆的矛盾清醒:一项混合方法前瞻性研究
- 批准号:
10896626 - 财政年份:2020
- 资助金额:
$ 42.82万 - 项目类别:
Goal directed cardiopulmonary resuscitation in cardiac arrest using a novel physiological target: A pilot mechanistic randomized control trial
使用新型生理目标进行心脏骤停的目标导向心肺复苏:一项试点机械随机对照试验
- 批准号:
10471231 - 财政年份:2020
- 资助金额:
$ 42.82万 - 项目类别:
Goal directed cardiopulmonary resuscitation in cardiac arrest using a novel physiological target: A pilot mechanistic randomized control trial
使用新型生理目标进行心脏骤停的目标导向心肺复苏:一项试点机械随机对照试验
- 批准号:
10228545 - 财政年份:2020
- 资助金额:
$ 42.82万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Fellowship Programs